Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.56%
SPX
-0.11%
IXIC
+0.35%
FTSE
-0.03%
N225
+1.84%
AXJO
-0.14%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
Health Care
zntl
Zentalis Pharmaceuticals
NASDAQ: ZNTL
+2.20 (+49.66%)
6.615
USD
At close at Apr 10, 20:43 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

No Cashu articles
Zentalis Pharmaceuticals currently has no Cashu-related articles

Latest Zentalis Pharmaceuticals News

benzinga.com

What's Behind The Surge In Zentalis Stock?

Feature Image for interests on Movers, News, Stock, Technology from benzinga.com
about 7 hours ago
benzinga.com

12 Health Care Stocks Moving In Tuesday's After-Market Session

Feature Image for interests on Bzi-Tfm, Healthcare, Movers, Stock from benzinga.com
about 2 months ago
prnewswire.com

Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026

Feature Image for interests on Biotechnology, Clinical Trials & Medical Discoveries, Health Care & Hospitals, Healthcare from prnewswire.com
3 months ago
benzinga.com

12 Health Care Stocks Moving In Friday's Intraday Session

Feature Image for interests on Bzi-Tfm, Financial Services, Healthcare, Movers from benzinga.com
3 months ago
benzinga.com

12 Health Care Stocks Moving In Thursday's After-Market Session

Feature Image for interests on Bzi-Tfm, Financial Services, Movers, Stock from benzinga.com
3 months ago
benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

Feature Image for interests on Bzi-Tfm, Healthcare, Movers, Stock from benzinga.com
3 months ago
finance.yahoo.com

FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers

Feature Image for interests on Clinical Development, Clinical Studies, Fda, Stock from finance.yahoo.com
over 1 year ago
finance.yahoo.com

Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies

Feature Image for interests on Biological Pathways, Biopharmaceutical Company, Clinical Development, Clinical Studies from finance.yahoo.com
over 1 year ago
finance.yahoo.com

Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024

Feature Image for interests on Biological Pathways, Biopharmaceutical Company, Combination, Dna Damage from finance.yahoo.com
over 1 year ago
finance.yahoo.com

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feature Image for interests on Biological Pathways, Biopharmaceutical Company, Clinical Trials, Compensation Committee Of Zentalis’ Board Of Directors from finance.yahoo.com
over 1 year ago
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.